It is of considerable interest that TGFβ2 was identified as a factor that contributes to barrier dysfunction, as previous studies have documented the elevation of TGFβ2 in the eyes of patients with glaucoma [54, 61–63]. This evidence concerns the gene TGFB2 and glaucoma.